The association between serum uric acid to high-density lipoprotein cholesterol ratio and heart failure: a

Zhujun Fang1, Zhijie Jiang1, Xiaojuan Wang1

  • 1Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.

PubMed

Insights

The serum uric acid to high-density lipoprotein cholesterol ratio (UHR) is linked to heart failure (HF). Higher UHR levels indicate an increased risk of HF, suggesting its potential as a biomarker.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Biomarker Research

Background:

  • Heart failure (HF) is closely associated with metabolic disorders.
  • The serum uric acid to high-density lipoprotein cholesterol ratio (UHR) is a recognized inflammatory and metabolic marker.
  • The specific association between UHR and HF risk requires further elucidation.

Purpose of the Study:

  • To investigate the relationship between serum UHR and the prevalence of heart failure (HF).
  • To assess the potential of UHR as a composite biomarker for HF risk assessment.

Main Methods:

  • Cross-sectional study of 28,169 participants from the NHANES (2003-2018).
  • Logistic regression analyses (univariate and multivariate) and subgroup analyses were performed.
  • Restricted cubic spline analysis was used to evaluate the nonlinear relationship between UHR and HF.

Main Results:

  • A positive correlation was found between LnUHR and HF after adjusting for confounders (OR=1.82).
  • Higher LnUHR levels (Q4 vs. Q1) were associated with increased HF risk (OR=1.71).
  • A stable association was observed across most subgroups, with a positive nonlinear trend and an inflection point at 5.52.

Conclusions:

  • LnUHR is confirmed as positively associated with heart failure (HF).
  • LnUHR demonstrates potential as a composite biomarker for HF.
  • Further large-scale prospective studies are needed to validate findings and explore mechanisms.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
291
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
241
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23